Ad:

Regkiron - which is the first coronavirus drug to be evaluated by the European Medicines Agency

Health
18-10-2021,
Mgr inż. Edyta Żyromska

You can read this text in 1 min.

Regkiron - which is the first coronavirus drug to be evaluated by the European Medicines Agency

PantherMedia

Prescription drugs

This news has been awaited by many - after long months of anticipation, the European Medicines Agency has started work on the assessment of the marketing authorisation application for the medicinal product Regkirona for the treatment of COVID-19 in adult patients.

Ad:
Want to keep up to date? Follow us on G o o g l e News
Related
Topics
Antibody Coronavirus Medication Regicron
See also in
español français deutsch polskim

The content and materials contained in this site are for educational and informational purposes. The publisher and editors of the site are not responsible for the effects of their application. It is imperative that you consult your doctor before applying the advice and tips contained in the site.